Surrogates of Mortality in Chronic Obstructive Pulmonary Disease

American Journal of Medicine

Volumn 119, Issue 10 SUPPL., 2006, Pages 54-62

  Cote, Claudia G ^a  

^a Bay Pines VA Medical Center   (United States)

Author keywords

BODE index; Chronic obstructive pulmonary disease; Mortality surrogates; Pulmonary rehabilitation; Treatment

Indexed keywords

AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORRELATION ANALYSIS; DISABILITY; DISEASE SEVERITY; DYSPNEA; EVALUATION; EXERCISE; HUMAN; HYPOXEMIA; MALNUTRITION; MORTALITY; PREDICTION; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

ANEMIA, HYPOCHROMIC; ANOXEMIA; DISABLED PERSONS; DYSPNEA; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMANS; INSPIRATORY CAPACITY; MALNUTRITION; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 33748741719     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.08.008     Document Type: Article

References (41)

1. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
2. Mannino D.M., Homa D.M., Akinbami L.J., Ford E.S., and Redd S.C. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 51 (2002) 1-16
3. Pauwels R. Global initiative for chronic obstructive lung diseases (GOLD): time to act. Eur Respir J 18 (2001) 901-902
4. Anthonisen N.R., Wright E.C., and Hodgkin J.E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 133 (1986) 14-20
5. Fletcher C., and Peto R. The natural history of chronic airflow obstruction. BMJ 1 (1977) 1645-1648
6. Scanlon P.D., Connett J.E., Waller L.A., Altose M.D., Bailey W.C., and Buist A.S. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study. Am J Respir Crit Care Med 161 (2000) 381-390
7. Casaburi R., Mahler D.A., Jones P.W., et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19 (2002) 217-224
8. Decramer M., Celli B., Tashkin D., et al. Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial. J Chron Obstruct Pulm Dis 1 (2004) 303-312
9. Gaissert H.A., Trulock E.P., Cooper J.D., Sundaresan R.S., and Patterson G.A. Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 111 (1996) 296-306
10. Nishimura K., Izumi T., Tsukino M., and Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 121 (2002) 1434-1440
11. Mahler D.A., Donohue J.F., Barbee R.A., et al. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 115 (1999) 957-965
12. O'Donnell D.E., Lam M., and Webb K.A. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 1557-1565
13. O'Donnell D.E., Fluge T., Gerken F., et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 23 (2004) 832-840
14. Guell R., Casan P., Belda J., et al. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 117 (2000) 976-983
15. Schols A.M., Soeters P.B., Dingemans A.M., Mostert R., Frantzen P.J., and Wouters E.F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147 (1993) 1151-1156
16. Engelen M.P., Schols A.M., Baken W.C., Wesseling G.J., and Wouters E.F. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 7 (1994) 1793-1797
17. Schols A.M., Slangen J., Volovics L., and Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
18. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in chronic obstructive lung disease: a clinical trial. Ann Intern Med 93 (1980) 391-398
19. Pinto-Plata V.M., Cote C., Cabral H., Taylor J., and Celli B.R. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 23 (2004) 28-33
20. Fishman A., Martinez F., Naunheim K., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 (2003) 2059-2073
21. O'Donnell D.E., Voduc N., Fitzpatrick M., and Webb K.A. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 24 (2004) 86-94
22. Cooper C.B. Assessment of pulmonary function in COPD. Semin Respir Crit Care Med 26 (2005) 246-252
23. Casanova C., Cote C., de Torres J.P., et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 591-597
24. Celli B., ZuWallack R., Wang S., and Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 124 (2003) 1743-1748
25. Similowski T., Agusti A., MacNee W., and Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J 27 (2006) 390-396
26. Chambellan A., Chailleux E., and Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 128 (2005) 1201-1208
27. Cote C., Zilberberg M., Mody S., and Celli B. Anemia is a predictor of mortality in patients with COPD. Proc Am Thorac Soc 2 (2005) A890 [abstract]
28. Goodnough L.T., and Nissenson A.R. Anemia and its clinical consequences in patients with chronic diseases. Am J Med 116 suppl 7A (2004) 1S-2S
29. Barnes P.J. Medical progress: chronic obstructive pulmonary disease. N Engl J Med 343 (2000) 269-280
30. Vernooy J.H., Kucukaycan M., Jacobs J.A., et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 1218-1224
31. Noguera A., Busquets X., Sauleda J., Villaverde J.M., MacNee W., and Agusti A.G.N. Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 1664-1668
32. Sin D.D., and Man S.F. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?. Thorax 61 (2006) 1-3
33. Yende S., Waterer G.W., Tolley E.A., et al. Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning subjects. Thorax 61 (2006) 10-16
34. Broekhuizen R., Wouters E.F., Creutzberg E.C., and Schols A.M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61 (2006) 17-22
35. Pinto-Plata V., Mullerova H., Toso J., et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61 (2006) 23-28
36. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
37. Cote C., Casanova C., Marin J.M., et al. The BODE index and the St. George's Questionnaire: associations and survival in COPD. Proc Am Thorac Soc 3 (2006) A851 [abstract]
38. Cote C., and Celli B. Effect of exacerbations of COPD on multidimensional body mass index, airflow obstruction, dyspnea, and exercise capacity: BODE index [abstract]. Chest 126 (2004) 840S
39. Ong K.C., Earnest A., and Lu S.J. A multidimensional grading system (BODE index) as predictor of hospitalizations for COPD. Chest 128 (2005) 3810-3816
40. Celli B.R. Pulmonary rehabilitation for COPD: a practical approach for improving ventilatory conditioning. Postgrad Med 103 (1998) 159-160 167-168, 173-176
41. Cote C.G., and Celli B.R. Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 26 (2005) 630-636